Pandemic Prep Funding SURGES: New Antivirals, Vaccines & Diagnostics!
24 Jul 2026 · 0 min
0:21
In this brief monologue, the speaker highlights that although public headlines have shifted away from COVID‑19, major U.S. funding agencies—NIH, BARDA, and ARPA‑H—are still allocating substantial resources to pandemic preparedness and biosecurity. The agencies are investing millions of dollars into three key areas: broad‑spectrum antiviral drugs, pan‑virus (universal) vaccine platforms, and rapid, adaptable diagnostic technologies that can be quickly deployed when a new outbreak emerges.
